DavidRandallGrosshansMD

Radiation Oncology • Houston, TX

MD Anderson Cancer Center

Join to view full profile

Dr. Grosshans is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grosshans' full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2005 - 2009
HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 2004 - 2005
University of Colorado School of Medicine Anschutz Medical CampusClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
TX State Medical License 2009 - 2026
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2023 - 2025
TN State Medical License 2023 - 2025
WA State Medical License 2023 - 2025
AL State Medical License 2023 - 2024
CO State Medical License 2004 - 2007
American Board of Radiology Radiation Oncology
Join now to see all

Clinical Trials

Proton Beam Therapy for Chordoma Patients Start of enrollment: 2006 Sep 18
Active, not recruiting
Phase 2
Proton Beam Therapy for Chondrosarcoma Start of enrollment: 2006 Apr 28
Active, not recruiting
Phase 2
Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy Start of enrollment: 2001 Jan 02
Completed
Phase 3
Radiation Therapy and Cardiac Enzymes Start of enrollment: 2008 Oct 06
Completed
LET Optimized IMPT in Treating Pediatric Patients With Ependymoma Start of enrollment: 2019 Apr 01
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Validation of the generalized stochastic microdosimetric model (GSM) over a broad range of LET and particle beam type: a unique model for accurate description of (ther...
Giulio Bordieri, Marta Missiaggia, Giorgio Cartechini, Marco Battestini, Lawrence Bronk
Physics in Medicine and Biology. 2024-12-11
Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?
Fada Guan, Lawrence Bronk, Matthew Kerr, Yuting Li, Leslie A Braby
Scientific Reports. 2024-10-24
2 citations
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
Mohammad H Abu-Arja, Austin L Brown, Jack M Su, M Fatih Okcu, Holly B Lindsay
Neuro-Oncology. 2024-10-03

Journal Articles

Dose–Volume Metrics and Their Relation to Memory Performance in Pediatric Brain Tumor Patients: A Preliminary Study
Kimberly P Raghubar, M Douglas Ris, Christina Limke, David Grosshans, E Mark Mahone, Pediatric Blood & Cancer

Press Mentions

Surviving Oligodendroglioma with Humor and GratitudeOctober 3rd, 2017
The Lancet Oncology: Proton Beam Therapy Offers Potential to Treat Childhood Brain Cancer with Fewer Severe Side Effects Than CoJanuary 30th, 2016